CGI files 2023 Annual Disclosure Documents
Stock Market Symbols
GIB.A (TSX)
GIB (NYSE)
cgi.com/newsroom
CGI has also filed its 2023 Annual Information Form with the Canadian securities regulators, as well as with the U.S. Securities and Exchange Commission as part of its Annual Report on Form 40-F, which also includes its previously-filed Fiscal 2023 Results.
An electronic version of CGI's 2023 annual filings, including its Management Proxy Circular, Annual Information Form and Annual Report on Form 40-F, are available on CGI's website at cgi.com/investors.
Notice and Access
CGI uses the Notice and Access rules adopted by Canadian securities regulators to reduce the volume of paper in the materials distributed for the Annual General Meeting of Shareholders. For the purposes of the Notice and Access process, the Management Proxy Circular and other relevant materials are available here and on the Canadian Securities Administrators' website www.sedarplus.ca.
Registered shareholders and non-objecting beneficial owners may request a paper copy of the materials by calling Computershare Investor Services Inc. toll free at 1-866-962-0498 (
Founded in 1976, CGI is among the largest independent IT and business consulting services firms in the world. With 91,500 consultants and professionals across the globe, CGI delivers an end-to-end portfolio of capabilities, from strategic IT and business consulting to systems integration, managed IT and business process services and intellectual property solutions. CGI works with clients through a local relationship model complemented by a global delivery network that helps clients digitally transform their organizations and accelerate results. CGI Fiscal 2023 reported revenue is
View original content:https://www.prnewswire.com/news-releases/cgi-files-2023-annual-disclosure-documents-302017191.html
SOURCE CGI Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026
- Georgia's $150,000 Residency Threshold Has Been In Effect Since March 2026
- EVIDENT Expands Its Pramana Digital Pathology Portfolio to Support Small and Medium-Sized Labs
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share